References
- Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease2010 Available from: http://www.goldcopd.orgAccessed December 21, 2012
- ShavelleRMPaculdoDRKushSJManninoDMStraussDJLife expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up StudyInt J Chron Obstruct Pulmon Dis2009413714819436692
- LozanoRNaghaviMForemanKGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet20123802095212823245604
- CorradoARossiAHow far is real life from COPD therapy guidelines? an Italian observational studyRespir Med201210698999722483189
- ShariffRCuevasCRWangYGuideline adherence in management of stable chronic obstructive pulmonary diseaseRespir Med20131071046105223639271
- HerrickHPleasantsRWheatonAGChronic obstructive pulmonary disease and associated health-care resource use – North Carolina, 2007 and 2009MMWR Morb Mortal Wkly Rep20126114314622377845
- RocheNLepageTBourcereauJTerriouxPGuidelines versus clinical practice in the treatment of chronic obstructive pulmonary diseaseEur Respir J200118690399011829094
- BuistASMcBurniaMAVollmerWMBOLD Collaborative Research GroupInternational variation in the prevalence of COPD (The BOLD Study): a population-based prevalence studyLancet200737074175017765523
- KocabasATurkyilmazSUnalanTUnder-diagnosis and under-treatment of COPD in Adana, Turkey (BOLD-Turkey Study)Eur Respir J200628Supp 50446s
- UnalBErgorGChronic Diseases and Risk Factors in Turkey SurveyAnkaraMinistry of Health of Turkey2013322
- FitchKIwasakiKPyensonBVariation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysisCurr Med Res Opin2011271425142921599554
- de Miguel-DiezJCarrasco-GarridoPRejas-GutierezJInappropriate overuse of inhaled corticosteroid for COPD patients: impact on health cost and health statusLung201118919920621499887
- AscheCVLeaderSPlauschinatCAdherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroidsInt J Chron Obstruct Pulmon Dis2012720120922500120
- Van NoordJABantjeTAElandMEKorduckiLCornelissenPJThe Dutch Tiotropium Study GroupA randomized controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary diseaseThorax200055428929410722768
- CasaburiRMahlerDAJonesPWA long-term evaluation of once daily inhaled tiotropium in chronic obstructive pulmonary diseaseEur Respir J200219221722411866001
- Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease2011 Available from: http://www.goldcopd.orgAccessed December 21, 2012
- SorianoJBLamprechtBRamírezASMortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient dataLancet Respir Med2015344345025995071
- ZysmanMPatoutMMiravitllesMCOPD and perception of the new GOLD document in Europe. Workshop from the Société de pneumologie de langue française (SPLF)Rev Mal Respir20143149951025012036
- Turkish Thoracic Society, COPD Working GroupReport of COPD Prevention, Diagnosis and Treatment 2014 Available from: www.toraks.org.trAccessed March 27, 2015
- YorgancıoğluAYardımNErgünPIntegration of GARD Turkey national program with other non-communicable diseases plans in TurkeyTuberk Toraks201058221322820865577